Literature DB >> 12351617

HER2 in brain metastases: issues of concordance, survival, and treatment.

Ilka B Fuchs, Maren Loebbecke, Helmut Buhler, Gisela Stoltenburg-Didinger, Bernhard Heine, Werner Lichtenegger, Gerard Schaller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12351617     DOI： 10.1200/JCO.2002.04.016

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  20 in total

Review 1.  Treatment of brain metastases: chemotherapy.

Authors:  Sean A Grimm
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

2.  Risk factors and survival outcome in cerebral metastatic breast cancer.

Authors:  C Bachmann; S Schmidt; A Staebler; J Schittenhelm; D Wallwiener; E M Grischke
Journal:  Med Oncol       Date:  2014-02-07       Impact factor: 3.064

3.  Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases.

Authors:  Renata Duchnowska; Jeff Sperinde; Ahmed Chenna; Weidong Huang; Jodi M Weidler; John Winslow; Mojgan Haddad; Agnes Paquet; Yolanda Lie; Tomasz Trojanowski; Tomasz Mandat; Anna Kowalczyk; Bogumiła Czartoryska-Arłukowicz; Barbara Radecka; Bożena Jarosz; Rafal Staszkiewicz; Ewa Kalinka-Warzocha; Małgorzata Chudzik; Wojciech Biernat; Jacek Jassem
Journal:  Neuro Oncol       Date:  2015-02-13       Impact factor: 12.300

4.  CNS metastases in breast cancer patients: prognostic implications of tumor subtype.

Authors:  C Bachmann; S Schmidt; A Staebler; T Fehm; F Fend; J Schittenhelm; D Wallwiener; E Grischke
Journal:  Med Oncol       Date:  2014-11-30       Impact factor: 3.064

5.  Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosis.

Authors:  Yawara Omoto; Masafumi Kurosumi; Yasuo Hozumi; Hanako Oba; Kaori Kawanowa; Hiroyuki Takei; Yoshikazu Yasuda
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

Review 6.  Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain.

Authors:  Cimona V Hinton; Shalom Avraham; Hava Karsenty Avraham
Journal:  Clin Exp Metastasis       Date:  2008-09-24       Impact factor: 5.150

7.  CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary.

Authors:  C Bachmann; E M Grischke; T Fehm; A Staebler; J Schittenhelm; D Wallwiener
Journal:  J Cancer Res Clin Oncol       Date:  2012-12-06       Impact factor: 4.553

Review 8.  Clinical applications of a peptide-based vaccine for glioblastoma.

Authors:  Charles W Kanaly; Dale Ding; Amy B Heimberger; John H Sampson
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

Review 9.  Emerging role of brain metastases in the prognosis of breast cancer patients.

Authors:  Amanda Hambrecht; Rahul Jandial; Josh Neman
Journal:  Breast Cancer (Dove Med Press)       Date:  2011-08-10

10.  Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature.

Authors:  Oscar B Goodman; Matthew I Milowsky; Jodi Kaplan; Maha Hussain; David M Nanus
Journal:  J Med Case Rep       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.